nodes	percent_of_prediction	percent_of_DWPC	metapath
Atenolol—ABCB1—Mitomycin—urinary bladder cancer	0.314	0.506	CbGbCtD
Atenolol—ABCB1—Gemcitabine—urinary bladder cancer	0.0905	0.146	CbGbCtD
Atenolol—ABCB1—Cisplatin—urinary bladder cancer	0.0657	0.106	CbGbCtD
Atenolol—ABCB1—Etoposide—urinary bladder cancer	0.0646	0.104	CbGbCtD
Atenolol—ABCB1—Doxorubicin—urinary bladder cancer	0.0441	0.0708	CbGbCtD
Atenolol—ABCB1—Methotrexate—urinary bladder cancer	0.0427	0.0686	CbGbCtD
Atenolol—Ibuprofen—UGT2B7—urinary bladder cancer	0.00337	0.402	CrCbGaD
Atenolol—Ibuprofen—CXCL8—urinary bladder cancer	0.0019	0.227	CrCbGaD
Atenolol—Ibuprofen—PPARG—urinary bladder cancer	0.00131	0.157	CrCbGaD
Atenolol—Chlorphenesin—PTGS2—urinary bladder cancer	0.00124	0.148	CrCbGaD
Atenolol—Cardiac failure—Doxorubicin—urinary bladder cancer	0.000588	0.00159	CcSEcCtD
Atenolol—Mood swings—Epirubicin—urinary bladder cancer	0.000587	0.00159	CcSEcCtD
Atenolol—Loss of consciousness—Etoposide—urinary bladder cancer	0.000585	0.00158	CcSEcCtD
Atenolol—Lethargy—Doxorubicin—urinary bladder cancer	0.000585	0.00158	CcSEcCtD
Atenolol—Hypotension—Fluorouracil—urinary bladder cancer	0.000585	0.00158	CcSEcCtD
Atenolol—Ataxia—Epirubicin—urinary bladder cancer	0.000583	0.00158	CcSEcCtD
Atenolol—Cough—Etoposide—urinary bladder cancer	0.000581	0.00157	CcSEcCtD
Atenolol—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000581	0.00157	CcSEcCtD
Atenolol—Tachycardia—Cisplatin—urinary bladder cancer	0.000579	0.00157	CcSEcCtD
Atenolol—Insomnia—Gemcitabine—urinary bladder cancer	0.000576	0.00156	CcSEcCtD
Atenolol—Pain in extremity—Doxorubicin—urinary bladder cancer	0.000574	0.00155	CcSEcCtD
Atenolol—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000574	0.00155	CcSEcCtD
Atenolol—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000572	0.00155	CcSEcCtD
Atenolol—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000568	0.00154	CcSEcCtD
Atenolol—Chest pain—Etoposide—urinary bladder cancer	0.000567	0.00153	CcSEcCtD
Atenolol—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.000566	0.00153	CcSEcCtD
Atenolol—Insomnia—Fluorouracil—urinary bladder cancer	0.000566	0.00153	CcSEcCtD
Atenolol—Somnolence—Gemcitabine—urinary bladder cancer	0.000566	0.00153	CcSEcCtD
Atenolol—Anorexia—Cisplatin—urinary bladder cancer	0.000566	0.00153	CcSEcCtD
Atenolol—Affect lability—Doxorubicin—urinary bladder cancer	0.000565	0.00153	CcSEcCtD
Atenolol—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000562	0.00152	CcSEcCtD
Atenolol—Discomfort—Etoposide—urinary bladder cancer	0.00056	0.00152	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	0.000558	0.00151	CcSEcCtD
Atenolol—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000558	0.00151	CcSEcCtD
Atenolol—Somnolence—Fluorouracil—urinary bladder cancer	0.000556	0.0015	CcSEcCtD
Atenolol—Ibuprofen—PTGS2—urinary bladder cancer	0.000555	0.0662	CrCbGaD
Atenolol—Hypotension—Cisplatin—urinary bladder cancer	0.000555	0.0015	CcSEcCtD
Atenolol—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000553	0.0015	CcSEcCtD
Atenolol—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000551	0.00149	CcSEcCtD
Atenolol—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00055	0.00149	CcSEcCtD
Atenolol—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.000549	0.00148	CcSEcCtD
Atenolol—Fatigue—Gemcitabine—urinary bladder cancer	0.000549	0.00148	CcSEcCtD
Atenolol—Confusional state—Etoposide—urinary bladder cancer	0.000548	0.00148	CcSEcCtD
Atenolol—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.000546	0.00148	CcSEcCtD
Atenolol—Pain—Gemcitabine—urinary bladder cancer	0.000544	0.00147	CcSEcCtD
Atenolol—Constipation—Gemcitabine—urinary bladder cancer	0.000544	0.00147	CcSEcCtD
Atenolol—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000544	0.00147	CcSEcCtD
Atenolol—Mood swings—Doxorubicin—urinary bladder cancer	0.000543	0.00147	CcSEcCtD
Atenolol—Asthenia—Thiotepa—urinary bladder cancer	0.000543	0.00147	CcSEcCtD
Atenolol—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00054	0.00146	CcSEcCtD
Atenolol—Ataxia—Doxorubicin—urinary bladder cancer	0.000539	0.00146	CcSEcCtD
Atenolol—Pruritus—Thiotepa—urinary bladder cancer	0.000535	0.00145	CcSEcCtD
Atenolol—Pain—Fluorouracil—urinary bladder cancer	0.000535	0.00145	CcSEcCtD
Atenolol—Paraesthesia—Cisplatin—urinary bladder cancer	0.000533	0.00144	CcSEcCtD
Atenolol—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000532	0.00144	CcSEcCtD
Atenolol—Tachycardia—Etoposide—urinary bladder cancer	0.000531	0.00143	CcSEcCtD
Atenolol—Dyspnoea—Cisplatin—urinary bladder cancer	0.000529	0.00143	CcSEcCtD
Atenolol—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000527	0.00143	CcSEcCtD
Atenolol—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000526	0.00142	CcSEcCtD
Atenolol—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000525	0.00142	CcSEcCtD
Atenolol—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.000524	0.00142	CcSEcCtD
Atenolol—Anorexia—Etoposide—urinary bladder cancer	0.000518	0.0014	CcSEcCtD
Atenolol—Diarrhoea—Thiotepa—urinary bladder cancer	0.000518	0.0014	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000517	0.0014	CcSEcCtD
Atenolol—Decreased appetite—Cisplatin—urinary bladder cancer	0.000516	0.0014	CcSEcCtD
Atenolol—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000516	0.0014	CcSEcCtD
Atenolol—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000512	0.00139	CcSEcCtD
Atenolol—Drowsiness—Methotrexate—urinary bladder cancer	0.000511	0.00138	CcSEcCtD
Atenolol—Depression—Methotrexate—urinary bladder cancer	0.000509	0.00138	CcSEcCtD
Atenolol—Hypotension—Etoposide—urinary bladder cancer	0.000508	0.00137	CcSEcCtD
Atenolol—Pain—Cisplatin—urinary bladder cancer	0.000507	0.00137	CcSEcCtD
Atenolol—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000503	0.00136	CcSEcCtD
Atenolol—Renal failure—Methotrexate—urinary bladder cancer	0.000502	0.00136	CcSEcCtD
Atenolol—Dizziness—Thiotepa—urinary bladder cancer	0.0005	0.00135	CcSEcCtD
Atenolol—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000495	0.00134	CcSEcCtD
Atenolol—Sweating—Methotrexate—urinary bladder cancer	0.000489	0.00132	CcSEcCtD
Atenolol—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000489	0.00132	CcSEcCtD
Atenolol—Paraesthesia—Etoposide—urinary bladder cancer	0.000488	0.00132	CcSEcCtD
Atenolol—Dyspnoea—Etoposide—urinary bladder cancer	0.000485	0.00131	CcSEcCtD
Atenolol—Somnolence—Etoposide—urinary bladder cancer	0.000483	0.00131	CcSEcCtD
Atenolol—Epistaxis—Methotrexate—urinary bladder cancer	0.000482	0.0013	CcSEcCtD
Atenolol—Drowsiness—Epirubicin—urinary bladder cancer	0.000478	0.00129	CcSEcCtD
Atenolol—Rash—Thiotepa—urinary bladder cancer	0.000477	0.00129	CcSEcCtD
Atenolol—Dermatitis—Thiotepa—urinary bladder cancer	0.000477	0.00129	CcSEcCtD
Atenolol—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000476	0.00129	CcSEcCtD
Atenolol—Headache—Thiotepa—urinary bladder cancer	0.000474	0.00128	CcSEcCtD
Atenolol—Decreased appetite—Etoposide—urinary bladder cancer	0.000473	0.00128	CcSEcCtD
Atenolol—Renal failure—Epirubicin—urinary bladder cancer	0.00047	0.00127	CcSEcCtD
Atenolol—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000469	0.00127	CcSEcCtD
Atenolol—Body temperature increased—Cisplatin—urinary bladder cancer	0.000469	0.00127	CcSEcCtD
Atenolol—Fatigue—Etoposide—urinary bladder cancer	0.000469	0.00127	CcSEcCtD
Atenolol—Pain—Etoposide—urinary bladder cancer	0.000465	0.00126	CcSEcCtD
Atenolol—Constipation—Etoposide—urinary bladder cancer	0.000465	0.00126	CcSEcCtD
Atenolol—Sweating—Epirubicin—urinary bladder cancer	0.000458	0.00124	CcSEcCtD
Atenolol—Asthenia—Gemcitabine—urinary bladder cancer	0.000457	0.00124	CcSEcCtD
Atenolol—Epistaxis—Epirubicin—urinary bladder cancer	0.000451	0.00122	CcSEcCtD
Atenolol—Pruritus—Gemcitabine—urinary bladder cancer	0.00045	0.00122	CcSEcCtD
Atenolol—Nausea—Thiotepa—urinary bladder cancer	0.00045	0.00122	CcSEcCtD
Atenolol—Feeling abnormal—Etoposide—urinary bladder cancer	0.000448	0.00121	CcSEcCtD
Atenolol—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000446	0.00121	CcSEcCtD
Atenolol—Pruritus—Fluorouracil—urinary bladder cancer	0.000443	0.0012	CcSEcCtD
Atenolol—Drowsiness—Doxorubicin—urinary bladder cancer	0.000442	0.0012	CcSEcCtD
Atenolol—Visual impairment—Methotrexate—urinary bladder cancer	0.000442	0.00119	CcSEcCtD
Atenolol—Bradycardia—Epirubicin—urinary bladder cancer	0.000437	0.00118	CcSEcCtD
Atenolol—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000436	0.00118	CcSEcCtD
Atenolol—Renal failure—Doxorubicin—urinary bladder cancer	0.000435	0.00118	CcSEcCtD
Atenolol—Body temperature increased—Etoposide—urinary bladder cancer	0.00043	0.00116	CcSEcCtD
Atenolol—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000428	0.00116	CcSEcCtD
Atenolol—Tinnitus—Methotrexate—urinary bladder cancer	0.000427	0.00116	CcSEcCtD
Atenolol—Asthenia—Cisplatin—urinary bladder cancer	0.000426	0.00115	CcSEcCtD
Atenolol—Sweating—Doxorubicin—urinary bladder cancer	0.000424	0.00115	CcSEcCtD
Atenolol—Epistaxis—Doxorubicin—urinary bladder cancer	0.000417	0.00113	CcSEcCtD
Atenolol—Dizziness—Fluorouracil—urinary bladder cancer	0.000414	0.00112	CcSEcCtD
Atenolol—Visual impairment—Epirubicin—urinary bladder cancer	0.000413	0.00112	CcSEcCtD
Atenolol—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000413	0.00112	CcSEcCtD
Atenolol—Diarrhoea—Cisplatin—urinary bladder cancer	0.000406	0.0011	CcSEcCtD
Atenolol—Alopecia—Methotrexate—urinary bladder cancer	0.000405	0.0011	CcSEcCtD
Atenolol—Bradycardia—Doxorubicin—urinary bladder cancer	0.000404	0.00109	CcSEcCtD
Atenolol—Rash—Gemcitabine—urinary bladder cancer	0.000401	0.00109	CcSEcCtD
Atenolol—Dermatitis—Gemcitabine—urinary bladder cancer	0.000401	0.00108	CcSEcCtD
Atenolol—Tinnitus—Epirubicin—urinary bladder cancer	0.0004	0.00108	CcSEcCtD
Atenolol—Headache—Gemcitabine—urinary bladder cancer	0.000399	0.00108	CcSEcCtD
Atenolol—Flushing—Epirubicin—urinary bladder cancer	0.000398	0.00108	CcSEcCtD
Atenolol—Rash—Fluorouracil—urinary bladder cancer	0.000395	0.00107	CcSEcCtD
Atenolol—Dermatitis—Fluorouracil—urinary bladder cancer	0.000394	0.00107	CcSEcCtD
Atenolol—Headache—Fluorouracil—urinary bladder cancer	0.000392	0.00106	CcSEcCtD
Atenolol—Asthenia—Etoposide—urinary bladder cancer	0.00039	0.00105	CcSEcCtD
Atenolol—Pruritus—Etoposide—urinary bladder cancer	0.000385	0.00104	CcSEcCtD
Atenolol—Arrhythmia—Epirubicin—urinary bladder cancer	0.000383	0.00104	CcSEcCtD
Atenolol—Visual impairment—Doxorubicin—urinary bladder cancer	0.000382	0.00103	CcSEcCtD
Atenolol—Alopecia—Epirubicin—urinary bladder cancer	0.000379	0.00103	CcSEcCtD
Atenolol—Nausea—Gemcitabine—urinary bladder cancer	0.000378	0.00102	CcSEcCtD
Atenolol—Vision blurred—Methotrexate—urinary bladder cancer	0.000376	0.00102	CcSEcCtD
Atenolol—Rash—Cisplatin—urinary bladder cancer	0.000374	0.00101	CcSEcCtD
Atenolol—Dermatitis—Cisplatin—urinary bladder cancer	0.000374	0.00101	CcSEcCtD
Atenolol—Diarrhoea—Etoposide—urinary bladder cancer	0.000372	0.00101	CcSEcCtD
Atenolol—Nausea—Fluorouracil—urinary bladder cancer	0.000372	0.00101	CcSEcCtD
Atenolol—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.00037	0.001	CcSEcCtD
Atenolol—Tinnitus—Doxorubicin—urinary bladder cancer	0.00037	0.001	CcSEcCtD
Atenolol—Flushing—Doxorubicin—urinary bladder cancer	0.000368	0.000996	CcSEcCtD
Atenolol—Tension—Epirubicin—urinary bladder cancer	0.000366	0.000991	CcSEcCtD
Atenolol—Nervousness—Epirubicin—urinary bladder cancer	0.000363	0.000981	CcSEcCtD
Atenolol—Malaise—Methotrexate—urinary bladder cancer	0.00036	0.000973	CcSEcCtD
Atenolol—Dizziness—Etoposide—urinary bladder cancer	0.00036	0.000972	CcSEcCtD
Atenolol—Vertigo—Methotrexate—urinary bladder cancer	0.000358	0.000969	CcSEcCtD
Atenolol—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000355	0.000959	CcSEcCtD
Atenolol—Nausea—Cisplatin—urinary bladder cancer	0.000352	0.000953	CcSEcCtD
Atenolol—Vision blurred—Epirubicin—urinary bladder cancer	0.000352	0.000952	CcSEcCtD
Atenolol—Alopecia—Doxorubicin—urinary bladder cancer	0.000351	0.000948	CcSEcCtD
Atenolol—Cough—Methotrexate—urinary bladder cancer	0.000348	0.000942	CcSEcCtD
Atenolol—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000346	0.000937	CcSEcCtD
Atenolol—Rash—Etoposide—urinary bladder cancer	0.000343	0.000927	CcSEcCtD
Atenolol—Dermatitis—Etoposide—urinary bladder cancer	0.000342	0.000926	CcSEcCtD
Atenolol—Headache—Etoposide—urinary bladder cancer	0.000341	0.000921	CcSEcCtD
Atenolol—Chest pain—Methotrexate—urinary bladder cancer	0.00034	0.000919	CcSEcCtD
Atenolol—Tension—Doxorubicin—urinary bladder cancer	0.000339	0.000917	CcSEcCtD
Atenolol—Malaise—Epirubicin—urinary bladder cancer	0.000337	0.000911	CcSEcCtD
Atenolol—Discomfort—Methotrexate—urinary bladder cancer	0.000336	0.000908	CcSEcCtD
Atenolol—Nervousness—Doxorubicin—urinary bladder cancer	0.000336	0.000907	CcSEcCtD
Atenolol—Vertigo—Epirubicin—urinary bladder cancer	0.000335	0.000907	CcSEcCtD
Atenolol—Syncope—Epirubicin—urinary bladder cancer	0.000335	0.000906	CcSEcCtD
Atenolol—Palpitations—Epirubicin—urinary bladder cancer	0.00033	0.000892	CcSEcCtD
Atenolol—Confusional state—Methotrexate—urinary bladder cancer	0.000328	0.000888	CcSEcCtD
Atenolol—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000328	0.000888	CcSEcCtD
Atenolol—Cough—Epirubicin—urinary bladder cancer	0.000326	0.000881	CcSEcCtD
Atenolol—Vision blurred—Doxorubicin—urinary bladder cancer	0.000326	0.000881	CcSEcCtD
Atenolol—Nausea—Etoposide—urinary bladder cancer	0.000323	0.000873	CcSEcCtD
Atenolol—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000321	0.000867	CcSEcCtD
Atenolol—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000319	0.000862	CcSEcCtD
Atenolol—Chest pain—Epirubicin—urinary bladder cancer	0.000318	0.00086	CcSEcCtD
Atenolol—Anxiety—Epirubicin—urinary bladder cancer	0.000317	0.000857	CcSEcCtD
Atenolol—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000315	0.000851	CcSEcCtD
Atenolol—Discomfort—Epirubicin—urinary bladder cancer	0.000314	0.000849	CcSEcCtD
Atenolol—Malaise—Doxorubicin—urinary bladder cancer	0.000312	0.000843	CcSEcCtD
Atenolol—Dry mouth—Epirubicin—urinary bladder cancer	0.000311	0.000841	CcSEcCtD
Atenolol—Vertigo—Doxorubicin—urinary bladder cancer	0.00031	0.000839	CcSEcCtD
Atenolol—Anorexia—Methotrexate—urinary bladder cancer	0.00031	0.000839	CcSEcCtD
Atenolol—Syncope—Doxorubicin—urinary bladder cancer	0.00031	0.000838	CcSEcCtD
Atenolol—Confusional state—Epirubicin—urinary bladder cancer	0.000307	0.000831	CcSEcCtD
Atenolol—Palpitations—Doxorubicin—urinary bladder cancer	0.000305	0.000826	CcSEcCtD
Atenolol—Oedema—Epirubicin—urinary bladder cancer	0.000305	0.000824	CcSEcCtD
Atenolol—Hypotension—Methotrexate—urinary bladder cancer	0.000304	0.000823	CcSEcCtD
Atenolol—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000304	0.000821	CcSEcCtD
Atenolol—Cough—Doxorubicin—urinary bladder cancer	0.000301	0.000815	CcSEcCtD
Atenolol—Shock—Epirubicin—urinary bladder cancer	0.0003	0.000811	CcSEcCtD
Atenolol—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000298	0.000807	CcSEcCtD
Atenolol—Tachycardia—Epirubicin—urinary bladder cancer	0.000297	0.000804	CcSEcCtD
Atenolol—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000295	0.000797	CcSEcCtD
Atenolol—Insomnia—Methotrexate—urinary bladder cancer	0.000295	0.000797	CcSEcCtD
Atenolol—Chest pain—Doxorubicin—urinary bladder cancer	0.000294	0.000795	CcSEcCtD
Atenolol—Anxiety—Doxorubicin—urinary bladder cancer	0.000293	0.000793	CcSEcCtD
Atenolol—Paraesthesia—Methotrexate—urinary bladder cancer	0.000292	0.000791	CcSEcCtD
Atenolol—Discomfort—Doxorubicin—urinary bladder cancer	0.000291	0.000786	CcSEcCtD
Atenolol—Anorexia—Epirubicin—urinary bladder cancer	0.00029	0.000786	CcSEcCtD
Atenolol—Dyspnoea—Methotrexate—urinary bladder cancer	0.00029	0.000785	CcSEcCtD
Atenolol—Somnolence—Methotrexate—urinary bladder cancer	0.000289	0.000783	CcSEcCtD
Atenolol—Dry mouth—Doxorubicin—urinary bladder cancer	0.000288	0.000778	CcSEcCtD
Atenolol—Dyspepsia—Methotrexate—urinary bladder cancer	0.000287	0.000775	CcSEcCtD
Atenolol—Hypotension—Epirubicin—urinary bladder cancer	0.000285	0.00077	CcSEcCtD
Atenolol—Confusional state—Doxorubicin—urinary bladder cancer	0.000284	0.000769	CcSEcCtD
Atenolol—Decreased appetite—Methotrexate—urinary bladder cancer	0.000283	0.000766	CcSEcCtD
Atenolol—Oedema—Doxorubicin—urinary bladder cancer	0.000282	0.000763	CcSEcCtD
Atenolol—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000281	0.00076	CcSEcCtD
Atenolol—Fatigue—Methotrexate—urinary bladder cancer	0.000281	0.000759	CcSEcCtD
Atenolol—Pain—Methotrexate—urinary bladder cancer	0.000278	0.000753	CcSEcCtD
Atenolol—Shock—Doxorubicin—urinary bladder cancer	0.000277	0.00075	CcSEcCtD
Atenolol—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000276	0.000747	CcSEcCtD
Atenolol—Insomnia—Epirubicin—urinary bladder cancer	0.000276	0.000745	CcSEcCtD
Atenolol—Tachycardia—Doxorubicin—urinary bladder cancer	0.000275	0.000744	CcSEcCtD
Atenolol—Paraesthesia—Epirubicin—urinary bladder cancer	0.000274	0.00074	CcSEcCtD
Atenolol—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000273	0.000737	CcSEcCtD
Atenolol—Dyspnoea—Epirubicin—urinary bladder cancer	0.000272	0.000735	CcSEcCtD
Atenolol—Somnolence—Epirubicin—urinary bladder cancer	0.000271	0.000733	CcSEcCtD
Atenolol—Anorexia—Doxorubicin—urinary bladder cancer	0.000269	0.000727	CcSEcCtD
Atenolol—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000268	0.000726	CcSEcCtD
Atenolol—Dyspepsia—Epirubicin—urinary bladder cancer	0.000268	0.000725	CcSEcCtD
Atenolol—Decreased appetite—Epirubicin—urinary bladder cancer	0.000265	0.000716	CcSEcCtD
Atenolol—Hypotension—Doxorubicin—urinary bladder cancer	0.000263	0.000713	CcSEcCtD
Atenolol—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000263	0.000712	CcSEcCtD
Atenolol—Fatigue—Epirubicin—urinary bladder cancer	0.000263	0.000711	CcSEcCtD
Atenolol—Pain—Epirubicin—urinary bladder cancer	0.000261	0.000705	CcSEcCtD
Atenolol—Constipation—Epirubicin—urinary bladder cancer	0.000261	0.000705	CcSEcCtD
Atenolol—Body temperature increased—Methotrexate—urinary bladder cancer	0.000257	0.000696	CcSEcCtD
Atenolol—Insomnia—Doxorubicin—urinary bladder cancer	0.000255	0.00069	CcSEcCtD
Atenolol—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000253	0.000685	CcSEcCtD
Atenolol—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000251	0.00068	CcSEcCtD
Atenolol—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000251	0.000679	CcSEcCtD
Atenolol—Somnolence—Doxorubicin—urinary bladder cancer	0.000251	0.000678	CcSEcCtD
Atenolol—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000248	0.000671	CcSEcCtD
Atenolol—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000245	0.000663	CcSEcCtD
Atenolol—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000243	0.000658	CcSEcCtD
Atenolol—Fatigue—Doxorubicin—urinary bladder cancer	0.000243	0.000657	CcSEcCtD
Atenolol—Constipation—Doxorubicin—urinary bladder cancer	0.000241	0.000652	CcSEcCtD
Atenolol—Pain—Doxorubicin—urinary bladder cancer	0.000241	0.000652	CcSEcCtD
Atenolol—Body temperature increased—Epirubicin—urinary bladder cancer	0.000241	0.000651	CcSEcCtD
Atenolol—Asthenia—Methotrexate—urinary bladder cancer	0.000234	0.000632	CcSEcCtD
Atenolol—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000232	0.000628	CcSEcCtD
Atenolol—Pruritus—Methotrexate—urinary bladder cancer	0.00023	0.000623	CcSEcCtD
Atenolol—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000223	0.000603	CcSEcCtD
Atenolol—Diarrhoea—Methotrexate—urinary bladder cancer	0.000223	0.000603	CcSEcCtD
Atenolol—Asthenia—Epirubicin—urinary bladder cancer	0.000219	0.000591	CcSEcCtD
Atenolol—Pruritus—Epirubicin—urinary bladder cancer	0.000216	0.000583	CcSEcCtD
Atenolol—Dizziness—Methotrexate—urinary bladder cancer	0.000215	0.000582	CcSEcCtD
Atenolol—Diarrhoea—Epirubicin—urinary bladder cancer	0.000209	0.000564	CcSEcCtD
Atenolol—Rash—Methotrexate—urinary bladder cancer	0.000205	0.000555	CcSEcCtD
Atenolol—Dermatitis—Methotrexate—urinary bladder cancer	0.000205	0.000555	CcSEcCtD
Atenolol—Headache—Methotrexate—urinary bladder cancer	0.000204	0.000552	CcSEcCtD
Atenolol—Asthenia—Doxorubicin—urinary bladder cancer	0.000202	0.000547	CcSEcCtD
Atenolol—Dizziness—Epirubicin—urinary bladder cancer	0.000202	0.000545	CcSEcCtD
Atenolol—Pruritus—Doxorubicin—urinary bladder cancer	0.000199	0.00054	CcSEcCtD
Atenolol—Nausea—Methotrexate—urinary bladder cancer	0.000193	0.000523	CcSEcCtD
Atenolol—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000193	0.000522	CcSEcCtD
Atenolol—Rash—Epirubicin—urinary bladder cancer	0.000192	0.00052	CcSEcCtD
Atenolol—Dermatitis—Epirubicin—urinary bladder cancer	0.000192	0.000519	CcSEcCtD
Atenolol—Headache—Epirubicin—urinary bladder cancer	0.000191	0.000516	CcSEcCtD
Atenolol—Dizziness—Doxorubicin—urinary bladder cancer	0.000186	0.000504	CcSEcCtD
Atenolol—Nausea—Epirubicin—urinary bladder cancer	0.000181	0.00049	CcSEcCtD
Atenolol—Rash—Doxorubicin—urinary bladder cancer	0.000178	0.000481	CcSEcCtD
Atenolol—Dermatitis—Doxorubicin—urinary bladder cancer	0.000178	0.00048	CcSEcCtD
Atenolol—Headache—Doxorubicin—urinary bladder cancer	0.000177	0.000478	CcSEcCtD
Atenolol—Nausea—Doxorubicin—urinary bladder cancer	0.000167	0.000453	CcSEcCtD
